ArticleFrontiers in surgery2025
The clinical spectrum of central neurocytomas ranges from benign to leptomeningeal disseminating disease: a single institutional surgical series of 33 patients.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Central neurocytomas (CN) are rare neuroepithelial neoplasms primarily found in the lateral ventricles. While generally considered benign, their clinical behavior varies, with some cases displaying atypical features associated with increased recurrence risk. Material and methods: This is a retrospective analysis of 33 adult CN patients that were operated and followed over a 25-year period by a single surgeon. Demographic (age, gender), anatomical (localization), histopathological (atypical histology, Ki67 index, p75NTR expression), extent of resection (GTR vs. STR), adjuvant treatments (radiotherapy and radiosurgery) were analyzed as potential prognostic factors. Results: Gross total resection (GTR) was associated with favorable outcomes, with adjuvant radiotherapy effective after subtotal resection (STR). Notably, a subset of aCN cases exhibited p75NTR immunopositivity, suggesting its potential as a prognostic marker for aggressive behavior. Leptomeningeal dissemination was rare but observed in one case. Conclusion: CN cases demonstrate clinical heterogeneity, emphasizing the importance of tailored management. Close follow-up is crucial, particularly in atypical cases, to optimize patient outcomes. GTR remains the goal in surgery, while p75NTR expression may serve as a prognostic indicator but further research is needed to validate p75NTR as a prognostic factor in CN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.